GlassScriptPhysician profile
Dona Hill
NPI 1265146369
$306.26
in general payments reported to CMS, 2019-2025
11 companies · $148 in 2025
The $148 reported for 2025 was less than what a typical Acute Care (Nurse Practitioner) provider received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $48.39 · 2024: $110 · 2025: $148.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $306.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $306.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $82.43 | 2024-2025 | Camzyos, Eliquis |
| Amgen INC. | $51.53 | 2024-2025 | Repatha, Repatha |
| Actelion Pharmaceuticals US, INC. | $25.85 | 2025 | Uptravi |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.44 | 2025 | Lifevest |
| Lilly USA, LLC | $20.69 | 2025 | Mounjaro, Zepbound |
| Merck Sharp & Dohme LLC | $18.41 | 2024 | Verquvo |
| Scpharmaceuticals INC. | $18.02 | 2025 | |
| Terumo Medical Corporation | $17.73 | 2023 | Glidewire, Glidesheath Slender |
| Medtronic, INC. | $17.12 | 2023 | Corevalve Evolut R |
| Novo Nordisk INC | $16.50 | 2024 | Ozempic, Rybelsus |
| Boston Scientific Corporation | $13.54 | 2023 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Dona Hill listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.